CH596130A5 - - Google Patents

Info

Publication number
CH596130A5
CH596130A5 CH383775A CH383775A CH596130A5 CH 596130 A5 CH596130 A5 CH 596130A5 CH 383775 A CH383775 A CH 383775A CH 383775 A CH383775 A CH 383775A CH 596130 A5 CH596130 A5 CH 596130A5
Authority
CH
Switzerland
Application number
CH383775A
Inventor
Henri Cousse
Gilbert Mouzin
Jean-Pierre Rieu
Original Assignee
Fabre Sa Pierre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7410196A external-priority patent/FR2265409A1/fr
Priority claimed from FR7504912A external-priority patent/FR2300551A2/fr
Application filed by Fabre Sa Pierre filed Critical Fabre Sa Pierre
Publication of CH596130A5 publication Critical patent/CH596130A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/185Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/86Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
CH383775A 1974-03-25 1975-03-25 CH596130A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7410196A FR2265409A1 (en) 1974-03-25 1974-03-25 4-Oxo-4-phenyl-2-methyl(ene)-butyric acid derivs. - analgesics, antiinflammatories and hypocholesterolemiants
FR7504912A FR2300551A2 (fr) 1975-02-17 1975-02-17 Nouveaux

Publications (1)

Publication Number Publication Date
CH596130A5 true CH596130A5 (xx) 1978-02-28

Family

ID=26218246

Family Applications (2)

Application Number Title Priority Date Filing Date
CH383875A CH595322A5 (xx) 1974-03-25 1975-03-25
CH383775A CH596130A5 (xx) 1974-03-25 1975-03-25

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH383875A CH595322A5 (xx) 1974-03-25 1975-03-25

Country Status (5)

Country Link
US (1) US4008323A (xx)
CH (2) CH595322A5 (xx)
DE (1) DE2513157A1 (xx)
ES (2) ES435949A1 (xx)
GB (1) GB1498903A (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271191A (en) * 1979-12-19 1981-06-02 Pierre Fabre S.A. Method of treating hyperuricemia and gout
FR2515037A1 (fr) * 1981-10-22 1983-04-29 Roussel Uclaf A titre de medicaments, certains derives mono-substitues de l'acide 4-phenyl 4-oxo buten-2-oique, ainsi que les compositions les renfermant
US4667055A (en) * 1983-12-29 1987-05-19 Merck Frosst Canada, Inc. Leukotriene antagonists
US4871756A (en) * 1985-03-20 1989-10-03 Merck Frosst Canada, Inc. Leukotriene antagonists
US5157022A (en) * 1989-11-22 1992-10-20 Adrian Barbul Method for reducing blood cholesterol using arginine
US5280045A (en) * 1991-10-16 1994-01-18 The Procter & Gamble Company 4(3,5-bis(1,1-dimethylethyl-4-hydroxyphenyl)-4-oxobutanamide compound useful as an anti-inflammatory agent
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
CA2174737C (en) * 1993-10-29 2008-04-22 Douglas V. Faller Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
AR002945A1 (es) * 1994-11-15 1998-05-27 Bayer Corp Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
GB9522615D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
GB9522617D0 (en) * 1995-11-03 1996-01-03 Pharmacia Spa 4-Phenyl-4-oxo-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
US6376546B1 (en) 1997-10-14 2002-04-23 Asahi Kasei Kabushiki Kaisha Biphenyl-5-alkanoic acid derivatives and use thereof
WO1999040883A2 (en) * 1998-02-11 1999-08-19 Faller Douglas V Compositions and methods for the treatment of cystic fibrosis
DE19835359A1 (de) 1998-08-05 2000-02-10 Clariant Gmbh Verfahren zur Herstellung von 4-(4'-Chlorbiphenyl-4-yl)-4-keto-2-methylenbuttersäure
WO2005035001A1 (en) * 2003-09-29 2005-04-21 Enos Pharmaceuticals, Inc. Sustained release l-arginine formulations and methods of manufacture and use
US20080145424A1 (en) * 2002-10-24 2008-06-19 Enos Phramaceuticals, Inc. Sustained release L-arginine formulations and methods of manufacture and use
KR20050083827A (ko) * 2002-10-24 2005-08-26 이노스 파마슈티칼스, 인코포레이티드 서방성 l-아르기닌 포뮬레이션 및 이의 제조방법 및 용도
WO2010105112A1 (en) * 2009-03-11 2010-09-16 Hemaquest Pharmaceuticals, Inc. Detection of short-chain fatty acids in biological samples
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
EP2509418A4 (en) 2009-12-08 2013-03-20 Hemaquest Pharmaceuticals Inc METHODS AND REGIMES AT LOW DOSE FOR TREATING RED GLOBULAR DISORDERS
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
AU2020283590A1 (en) 2019-05-31 2022-01-20 Viracta Subsidiary, Inc. Methods of treating virally associated cancers with histone deacetylase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452081A (en) * 1965-05-27 1969-06-24 Merck & Co Inc Phenoxy substituted 2-alkenoic acids
BE708617A (xx) 1966-12-30 1968-06-28
US3754021A (en) * 1968-05-29 1973-08-21 Merck & Co Inc 4-keto-4-(3-chloro-4'-cyclohexyl)phenylbutyric acid and related compounds
US3919304A (en) * 1968-10-25 1975-11-11 Ciba Geigy Corp {62 -Hydroxy-{62 -(cycloalkenylphenyl)alkanoic acids, esters and salts
BE759053A (fr) 1969-11-17 1971-05-17 Thomae Gmbh Dr K Nouveaux acides hydroxycrotoniques et procedes pour les fabriquer
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2103749A1 (en) * 1971-01-27 1972-08-10 Dr. Karl Thomae GmbH, 7951 Biberach 3-acyl-acrylic acids prepn - from a ketone and glyoxylic acid (deriv)
BE788749A (fr) * 1971-09-13 1973-03-13 Takeda Chemical Industries Ltd Acide 3-(benzoyl trisubstitue)-propionique et son procede de preparation
US3860722A (en) * 1972-09-22 1975-01-14 Richardson Merrell Inc Hypolipidemic agents

Also Published As

Publication number Publication date
GB1498903A (en) 1978-01-25
ES435949A1 (es) 1976-12-16
DE2513157C2 (xx) 1987-12-10
DE2513157A1 (de) 1975-10-09
ES435950A1 (es) 1976-12-16
US4008323A (en) 1977-02-15
CH595322A5 (xx) 1978-02-15

Similar Documents

Publication Publication Date Title
HU170628B (xx)
FR2277360B1 (xx)
FR2265864A1 (xx)
FR2264622A1 (xx)
FR2263392B1 (xx)
FR2265409B1 (xx)
FR2273024A1 (xx)
FR2275768B1 (xx)
AU495930B2 (xx)
DK20874A (xx)
CS167793B1 (xx)
CS167155B1 (xx)
BG19768A1 (xx)
AU480208A (xx)
CH596130A5 (xx)
BG19987A1 (xx)
BG20440A1 (xx)
BG20885A1 (xx)
BG20446A1 (xx)
BG20451A1 (xx)
BG20462A1 (xx)
BG20638A1 (xx)
BG20883A1 (xx)
AU480863A (xx)
AU480758A (xx)

Legal Events

Date Code Title Description
PL Patent ceased